Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Microbots for Drug delivery and monitoring Application-(BODEGA)

Reference number
Coordinator Uppsala universitet - Uppsala universitet Inst för elektroteknik
Funding from Vinnova SEK 1 000 000
Project duration September 2023 - May 2024
Status Completed
Venture Emerging technology solutions
Call Emerging technology solutions stage 1 2023

Important results from the project

The aim of the BODEGA project was to develop a proof of concept of a soft miniature robot that can move autonomously through complex pathways similar to the human vascular system and that can perform targeted therapies useful for cardiovascular and cancer treatments. Considerations were also made to ensure that the technologies developed in the project would result in the creation of affordable and sustainable devices that will help deliver efficient and quality robotic treatments to large populations and provide gender equal treatment through customisation.

Expected long term effects

The BODEGA project developed a versatile microbot for navigating autonomously through phantom channels mimicking human vascular systems and performing targeted interventions. Validated in both fluid-filled 3D printed and phantom vascular channels Its amphibious capability effectively navigates intricate pathways. Equipped with a needle-pointed tool, the microbot demonstrates microsurgical precision through individual limb movements, performing tasks like incisions and injections. These advancements promise enhanced minimally invasive and targeted treatments.

Approach and implementation

The fabrication of the BODEGA microbot was made through hybrid additive manufacturing for rapid, low cost and customisable production.The customisable and scalable property of the developed robot allows gender equal treatments by accomodating the specific needs equally. A three-layer cylindrical model was simulated for the vascular channels and was optmised for Fat intrabody communication. The microbot’s autonomous locomotion was refined to navigate simulated and dynamic vascular systems effectively. The robot developed is fully biocompatible and sustainable.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 28 June 2024

Reference number 2023-01451